Seeking Alpha

Par Pharmaceutical (PRX +0.2%) says that its operating subsidiary has begun shipping 5 mg and 10...

Par Pharmaceutical (PRX +0.2%) says that its operating subsidiary has begun shipping 5 mg and 10 mg strengths of rizatriptan benzoate tablets. Rizatriptan benzoate is indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age. Annual U.S. sales of the drug total approximately $653M.
From other sites
Comments (1)
  • Boomerdude
    , contributor
    Comments (113) | Send Message
     
    Rizatriptan is a generic drug of the "triptan" class, marketed by Merck as Maxalt. This is not the first generic triptan on the market (sumatriptan is), but it is a widely used and commonly effective treatment. Par is privately held.
    2 Jan 2013, 12:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs